BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 31399894)

  • 1. Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.
    Hirano Y; Ii Y
    Clin Drug Investig; 2019 Nov; 39(11):1077-1092. PubMed ID: 31399894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of medical service fee revision on reducing irrational psychotropic polypharmacy in Japan: an interrupted time-series analysis.
    Okada Y; Akazawa M
    Soc Psychiatry Psychiatr Epidemiol; 2022 Feb; 57(2):411-422. PubMed ID: 34333670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Extrapyramidal Syndromes Associated With Psychotropic Polypharmacy: A Study Based on Large-Scale Japanese Claims Data.
    Hirano Y
    Ther Innov Regul Sci; 2020 Mar; 54(2):259-268. PubMed ID: 31933179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of medical fee revisions for psychotropic polypharmacy in patients with mood disorders in Japan: An interrupted time-series analysis using a nationwide inpatient database.
    Yamazaki R; Ohbe H; Matsuda Y; Kito S; Shigeta M; Morita K; Matsui H; Fushimi K; Yasunaga H
    Asian J Psychiatr; 2023 Jun; 84():103581. PubMed ID: 37086613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture.
    Takahashi T; Otsubo T; Kunisawa S; Sasaki N; Imanaka Y
    Neuropsychopharmacol Rep; 2020 Sep; 40(3):224-231. PubMed ID: 32452649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in antipsychotic prescriptions for Japanese outpatients during 2006-2012: a descriptive epidemiological study.
    Kochi K; Sato I; Nishiyama C; Tanaka-Mizuno S; Doi Y; Arai M; Fujii Y; Matsunaga T; Ogawa Y; Furukawa TA; Kawakami K
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):642-656. PubMed ID: 28266090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing Trends Psychotropic Drugs Against Children and Adolescents and Association with Polypharmacy Reduction Policy for Psychotropic Drugs: Based on Japanese National Database Survey.
    Park J; Okui T; Nakashima N
    Stud Health Technol Inform; 2022 Jun; 290():1132-1133. PubMed ID: 35673241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
    Chakos M; Patel JK; Rosenheck R; Glick ID; Hammer MB; Tapp A; Miller A; Miller D
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):124-34. PubMed ID: 21983496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database.
    Okuda S; Qureshi ZP; Yanagida Y; Ito C; Homma Y; Tokita S
    BMC Psychiatry; 2023 Apr; 23(1):278. PubMed ID: 37081408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in prescribing of hypnotics, anxiolytics and antidepressants between 61 general practices.
    Pharoah PD; Melzer D
    Br J Gen Pract; 1995 Nov; 45(400):595-9. PubMed ID: 8554839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic medication in a randomly selected group of citizens receiving residential or home care.
    Futtrup TB; Helnæs AK; Schultz H; Jensen M; Reuther LØ
    Dan Med J; 2014 Dec; 61(12):A4965. PubMed ID: 25441727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018.
    Klau J; Bernardo CO; Gonzalez-Chica DA; Raven M; Jureidini J
    Aust N Z J Psychiatry; 2022 Nov; 56(11):1477-1490. PubMed ID: 34963342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of regional differences in the amount of hypnotic and anxiolytic prescriptions in Japan using nationwide claims data.
    Okui T; Park J
    BMC Psychiatry; 2022 Jan; 22(1):44. PubMed ID: 35045851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How psychotropic polypharmacy in schizophrenia begins: a longitudinal perspective.
    Shinfuku M; Uchida H; Tsutsumi C; Suzuki T; Watanabe K; Kimura Y; Tsutsumi Y; Ishii K; Imasaka Y; Mimura M; Kapur S
    Pharmacopsychiatry; 2012 Jun; 45(4):133-7. PubMed ID: 22174025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics.
    Yang SY; Chen LY; Najoan E; Kallivayalil RA; Viboonma K; Jamaluddin R; Javed A; Hoa DTQ; Iida H; Sim K; Swe T; He YL; Park Y; Ahmed HU; De Alwis A; Chiu HF; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):572-579. PubMed ID: 29761577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antidepressants, anxiolytics and hypnotics prescribed to young adults before and after an economic crisis in Iceland - A cross-sectional study at the Primary Health Care of Reykjavik capital area].
    Arnarson A; Jonsson JS; Tomasdottir MO; Sigurdsson EL
    Laeknabladid; 2019 Oktober; 105(10):427-432. PubMed ID: 31571605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland.
    Gobert M; D'hoore W
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):712-21. PubMed ID: 16035123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
    Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
    Inoue Y; Okumura Y; Fujita J
    Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the economic crisis on consumption of psychotropic drugs in Asturias (Spain)].
    Nicieza-García ML; Alonso-Lorenzo JC; Suárez-Gil P; Rilla-Villar N
    Gac Sanit; 2016; 30(6):464-467. PubMed ID: 27017197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.